Protein interactions, network pharmacology, and machine learning work together to predict genes linked to mitochondrial dysfunction in hypertrophic cardiomyopathy

Abstract This study looked at possible targets for hypertrophic cardiomyopathy (HCM), a condition marked by thickening of the ventricular wall, primarily in the left ventricle. We employed differential gene analysis and weighted gene co-expression network analysis (WGCNA) on samples. We then carried...

Full description

Saved in:
Bibliographic Details
Main Authors: Jia-lin Chen, Di Xiao, Yi-jiang Liu, Zhan Wang, Zhi-huang Chen, Rui Li, Li Li, Rong-hai He, Shu-yan Jiang, Xin Chen, Lin-xi Xu, Feng-chun Lu, Jia-mao Wang, Zhong-gui Shan
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-97534-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850042087221755904
author Jia-lin Chen
Di Xiao
Yi-jiang Liu
Zhan Wang
Zhi-huang Chen
Rui Li
Li Li
Rong-hai He
Shu-yan Jiang
Xin Chen
Lin-xi Xu
Feng-chun Lu
Jia-mao Wang
Zhong-gui Shan
author_facet Jia-lin Chen
Di Xiao
Yi-jiang Liu
Zhan Wang
Zhi-huang Chen
Rui Li
Li Li
Rong-hai He
Shu-yan Jiang
Xin Chen
Lin-xi Xu
Feng-chun Lu
Jia-mao Wang
Zhong-gui Shan
author_sort Jia-lin Chen
collection DOAJ
description Abstract This study looked at possible targets for hypertrophic cardiomyopathy (HCM), a condition marked by thickening of the ventricular wall, primarily in the left ventricle. We employed differential gene analysis and weighted gene co-expression network analysis (WGCNA) on samples. We then carried out an enrichment analysis. We also investigated the process of immunological infiltration. We employed six machine learning techniques and two protein–protein interaction (PPI) network gene selection approaches to search for the most characteristic gene (MCG). In the validation ladder, we verified the expression of MCG. Furthermore, we examined the MCG expression levels in HCM animal and cell models. Finally, we performed molecular docking and predicted potential medications for HCM treatment. 7975 differentially expressed genes (DEGs) were found in our study. We also identified 236 genes in the blue module using WGCNA. Screening at the transcriptome and protein levels was used to mine MCG. The final result screened CCAAT/Enhancer Binding Protein Delta (CEBPD) as MCG. We confirmed that MCG expression matched the outcomes of the experimental ladder. The level of CEBPD mRNA and protein was lowered in HCM animal and cellular models. Given that Abt-751 had the highest binding affinity to CEBPD, it might be a projected targeted medication. We found a new target gene for HCM called CEBPD, which is probably going to function by mitochondrial dysfunction. An innovative aim for the management or avoidance of HCM is offered by this analysis. Abt-751 may be a predicted targeted drug for HCM that had the greatest binding affinity with CEBPD.
format Article
id doaj-art-ee041270c1574290aa571f1d8dc61255
institution DOAJ
issn 2045-2322
language English
publishDate 2025-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-ee041270c1574290aa571f1d8dc612552025-08-20T02:55:38ZengNature PortfolioScientific Reports2045-23222025-04-0115112310.1038/s41598-025-97534-xProtein interactions, network pharmacology, and machine learning work together to predict genes linked to mitochondrial dysfunction in hypertrophic cardiomyopathyJia-lin Chen0Di Xiao1Yi-jiang Liu2Zhan Wang3Zhi-huang Chen4Rui Li5Li Li6Rong-hai He7Shu-yan Jiang8Xin Chen9Lin-xi Xu10Feng-chun Lu11Jia-mao Wang12Zhong-gui Shan13The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen UniversityThe First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen UniversityThe First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen UniversityThe First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen UniversityThe First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen UniversityThe First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen UniversityThe First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen UniversityDepartment of Cardiac Surgery, Xiangan Hospital of Xiamen University, School of Medicine, Xiamen UniversityThe First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen UniversityThe First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen UniversityThe First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen UniversityDepartment of General Surgery, Fujian Medical University Union HospitalThe First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen UniversityThe First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen UniversityAbstract This study looked at possible targets for hypertrophic cardiomyopathy (HCM), a condition marked by thickening of the ventricular wall, primarily in the left ventricle. We employed differential gene analysis and weighted gene co-expression network analysis (WGCNA) on samples. We then carried out an enrichment analysis. We also investigated the process of immunological infiltration. We employed six machine learning techniques and two protein–protein interaction (PPI) network gene selection approaches to search for the most characteristic gene (MCG). In the validation ladder, we verified the expression of MCG. Furthermore, we examined the MCG expression levels in HCM animal and cell models. Finally, we performed molecular docking and predicted potential medications for HCM treatment. 7975 differentially expressed genes (DEGs) were found in our study. We also identified 236 genes in the blue module using WGCNA. Screening at the transcriptome and protein levels was used to mine MCG. The final result screened CCAAT/Enhancer Binding Protein Delta (CEBPD) as MCG. We confirmed that MCG expression matched the outcomes of the experimental ladder. The level of CEBPD mRNA and protein was lowered in HCM animal and cellular models. Given that Abt-751 had the highest binding affinity to CEBPD, it might be a projected targeted medication. We found a new target gene for HCM called CEBPD, which is probably going to function by mitochondrial dysfunction. An innovative aim for the management or avoidance of HCM is offered by this analysis. Abt-751 may be a predicted targeted drug for HCM that had the greatest binding affinity with CEBPD.https://doi.org/10.1038/s41598-025-97534-xHypertrophic cardiomyopathyImmune microenvironmentMachine learningMitochondrial dysfunctionMolecular dockingBioinformatics
spellingShingle Jia-lin Chen
Di Xiao
Yi-jiang Liu
Zhan Wang
Zhi-huang Chen
Rui Li
Li Li
Rong-hai He
Shu-yan Jiang
Xin Chen
Lin-xi Xu
Feng-chun Lu
Jia-mao Wang
Zhong-gui Shan
Protein interactions, network pharmacology, and machine learning work together to predict genes linked to mitochondrial dysfunction in hypertrophic cardiomyopathy
Scientific Reports
Hypertrophic cardiomyopathy
Immune microenvironment
Machine learning
Mitochondrial dysfunction
Molecular docking
Bioinformatics
title Protein interactions, network pharmacology, and machine learning work together to predict genes linked to mitochondrial dysfunction in hypertrophic cardiomyopathy
title_full Protein interactions, network pharmacology, and machine learning work together to predict genes linked to mitochondrial dysfunction in hypertrophic cardiomyopathy
title_fullStr Protein interactions, network pharmacology, and machine learning work together to predict genes linked to mitochondrial dysfunction in hypertrophic cardiomyopathy
title_full_unstemmed Protein interactions, network pharmacology, and machine learning work together to predict genes linked to mitochondrial dysfunction in hypertrophic cardiomyopathy
title_short Protein interactions, network pharmacology, and machine learning work together to predict genes linked to mitochondrial dysfunction in hypertrophic cardiomyopathy
title_sort protein interactions network pharmacology and machine learning work together to predict genes linked to mitochondrial dysfunction in hypertrophic cardiomyopathy
topic Hypertrophic cardiomyopathy
Immune microenvironment
Machine learning
Mitochondrial dysfunction
Molecular docking
Bioinformatics
url https://doi.org/10.1038/s41598-025-97534-x
work_keys_str_mv AT jialinchen proteininteractionsnetworkpharmacologyandmachinelearningworktogethertopredictgeneslinkedtomitochondrialdysfunctioninhypertrophiccardiomyopathy
AT dixiao proteininteractionsnetworkpharmacologyandmachinelearningworktogethertopredictgeneslinkedtomitochondrialdysfunctioninhypertrophiccardiomyopathy
AT yijiangliu proteininteractionsnetworkpharmacologyandmachinelearningworktogethertopredictgeneslinkedtomitochondrialdysfunctioninhypertrophiccardiomyopathy
AT zhanwang proteininteractionsnetworkpharmacologyandmachinelearningworktogethertopredictgeneslinkedtomitochondrialdysfunctioninhypertrophiccardiomyopathy
AT zhihuangchen proteininteractionsnetworkpharmacologyandmachinelearningworktogethertopredictgeneslinkedtomitochondrialdysfunctioninhypertrophiccardiomyopathy
AT ruili proteininteractionsnetworkpharmacologyandmachinelearningworktogethertopredictgeneslinkedtomitochondrialdysfunctioninhypertrophiccardiomyopathy
AT lili proteininteractionsnetworkpharmacologyandmachinelearningworktogethertopredictgeneslinkedtomitochondrialdysfunctioninhypertrophiccardiomyopathy
AT ronghaihe proteininteractionsnetworkpharmacologyandmachinelearningworktogethertopredictgeneslinkedtomitochondrialdysfunctioninhypertrophiccardiomyopathy
AT shuyanjiang proteininteractionsnetworkpharmacologyandmachinelearningworktogethertopredictgeneslinkedtomitochondrialdysfunctioninhypertrophiccardiomyopathy
AT xinchen proteininteractionsnetworkpharmacologyandmachinelearningworktogethertopredictgeneslinkedtomitochondrialdysfunctioninhypertrophiccardiomyopathy
AT linxixu proteininteractionsnetworkpharmacologyandmachinelearningworktogethertopredictgeneslinkedtomitochondrialdysfunctioninhypertrophiccardiomyopathy
AT fengchunlu proteininteractionsnetworkpharmacologyandmachinelearningworktogethertopredictgeneslinkedtomitochondrialdysfunctioninhypertrophiccardiomyopathy
AT jiamaowang proteininteractionsnetworkpharmacologyandmachinelearningworktogethertopredictgeneslinkedtomitochondrialdysfunctioninhypertrophiccardiomyopathy
AT zhongguishan proteininteractionsnetworkpharmacologyandmachinelearningworktogethertopredictgeneslinkedtomitochondrialdysfunctioninhypertrophiccardiomyopathy